Peptable

Comparison

Exenatide vs Selank

Function

While Exenatide is used for type 2 diabetes treatment to improve glycemic control and modestly reduce body weight through GLP-1–like insulinotropic and glucagonostatic effects6768, Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39.

Mechanism

While Exenatide works as a 39-amino-acid exendin-4 peptide originally isolated from Gila monster venom that acts as a long-acting GLP-1 receptor agonist resistant to DPP-4 degradation67, Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39.

Receptor

Exenatide

GLP-1 receptor (GLP1R) 6780

Selank

Not clearly established in the current dataset.

Organism or Origin

Exenatide

Originally from Heloderma suspectum (Gila monster) venom; now produced synthetically67

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

Gene

Exenatide

Not assigned in the current dataset.

Selank

Not assigned in the current dataset.

Summary

Exenatide and Selank are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Exenatide is more often discussed in the realm of Metabolic and endocrine, whereas Selank is more often associated with the realm of Neurology and brain health and Immunology and inflammation. They also influence different molecular systems, with Exenatide tracking more closely to GLP-1 receptor while Selank centers more on GPCR receptor. Exenatide has a more venom-derived origin, while Selank is closer to synthetic analog background and their development context also differs, with Exenatide approved while Selank is approved for Research use only. Exenatide incorporates amidation features that are not part of Selank, while their sequence patterns also diverge, with Exenatide showing alpha-helical domain features and Selank showing proline-rich features.